-
MOQ
100 Pack(s)
-
Supply Type
Manufacturer, Supplier
Preferred Buyer From :
All over the world
Nimotuzumab is a humanized monoclonal antibody that as of 2014 had orphan status in the US and EU for glioma, and marketing approval in India, China, and other countries for squamous cell carcinomas of the head and neck, and was undergoing several clinical trials.